Importance of Mergers and Acquisitions (M&As) in the Pharmaceutical Industry
Healthcare is a key segment of the $SPX500 occupying ~15% of the total index allocation and on a 10 year times frame it outperformed the index by 0.3% on an annual basis. This sector is now under attack by current US administration, first with the inflation reduction act, and now by attempting to block M&A.